SEC Form 4 · accession 0001140361-16-062637
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John L Erb
Director
Period of report
Apr 28, 2016
Accepted (ET)
Apr 29, 2016 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 28, 2016 | M | 10,000 | $9.61 | A | 20,306 | D | |
| Common StockF1 | Apr 28, 2016 | S | 10,000 | $35.58 | D | 10,306 | D | |
| Common Stock | holding | — | — | — | 10,306 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $9.61 | Apr 28, 2016 | M | 10,000 | D | — | Apr 22, 2020 | Common Stock | 10,000 | 0 | D |
| Stock Option (Right to Buy)F2 | $11.72 | holding | — | — | — | — | Apr 22, 2021 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $35.31 to $35.75 per share. Mr. Erb has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
- F2100% fully vested.